New York-Presbyterian Hospital | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

46,289 results for “New York-Presbyterian Hospital”

Trials

View all 16060 →

Primary-care-provider Identification And Notification

7,023 participants · First posted Nov 15, 2013

Hospital Outcomes: Intervention in Moderately III Patients

444 participants · First posted Nov 21, 2005

Ambulatory Care Characteristics as Predictors of Mortality and Re-Admission

302 participants · First posted Sep 22, 2005

Drugs

View all 927 →

multivalent peptoids oligomers (New York University)

Anti-TNF monoclonal antibody(New York Hospital)

MTB Fatty Acid Biosynthesis Enzyme Inhibitors (State University of New York at Stony Brook)

Organizations

View all 2598 →

New York Presbyterian Hospital

United States

New York Presbyterian Hospital \ Weill Cornell University Medical Center

United States

THE NEW YORK AND PRESBYTERIAN HOSPITAL

United States

News

View all 26704 →

Milestone Pharmaceuticals to Present Etripamil PSVT Data at AHA Scientific Sessions 2025

Mitsubishi Tanabe Pharma to Present Phase 3 Data on Continuous Levodopa Infusion ND0612 for Parkinson's Disease

OncoDaily Medical Journal Expands Editorial Board with 20 Oncology Specialists Across 12 Countries

Page 1 of 4629